Advertisement

Topics

BRIEF-GSK's lung drug gains approval in Japan

21:11 EST 1 Dec 2016 | Reuters

* Relvar Ellipta 100/25 mcg gains approval in Japan for use in patients with COPD

Original Article: BRIEF-GSK's lung drug gains approval in Japan

NEXT ARTICLE

More From BioPortfolio on "BRIEF-GSK's lung drug gains approval in Japan"

Quick Search
Advertisement